Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol hydrochloride

Client Email

Product

1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride
Dexpropranolol
Dexpropranolol Hydrochloride
US Patents

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 24 USDMF, 2 CEP/COS, 2 JDMF, 4 EU WC, 9 NDC API, 19 Listed Suppliers, $ API Reference Price

43 API Suppliers
24 USDMF
2 CEP/COS
2 JDMF
4 EU WC
9 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

343 FDF Dossiers, 209 FDA Orange Book, 44 Europe, 14 Canada, 12 Australia, 16 South Africa, 48 Listed Dossiers

343 FDF Dossiers
209 FDA Orange Book
44 Europe
14 Canada
12 Australia
16 South Africa
48 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 160MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, CAPSULE, EXTENDED RELEASE;ORAL - 80MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 80MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG
CAPSULE, EXTENDED RELEASE;ORAL - 160MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
CAPSULE, EXTENDED RELEASE;ORAL - 80MG
CAPSULE, EXTENDED RELEASE;ORAL - 120MG
CAPSULE, EXTENDED RELEASE;ORAL - 80MG

RELATED EXCIPIENT COMPANIES

1 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 9 DKSH, 1 Jai Radhe Sales, 4 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 25 BASF, 1 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 35 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 36 Direct Compression, 33 Controlled & Modified Release, 31 Disintegrants & Superdisintegrants, 28 Thickeners and Stabilizers, 27 Granulation, 22 Film Formers & Plasticizers, 21 Taste Masking, 20 Lubricants & Glidants, 18 Co-Processed Excipients, 15 Solubilizers, 13 Topical, 11 Parenteral, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Emulsifying Agents, 5 API Stability Enhancers, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

84 Fillers, Diluents & Binders
54 Coating Systems & Additives
36 Direct Compression
33 Controlled & Modified Release
31 Disintegrants & Superdisintegrants
28 Thickeners and Stabilizers
27 Granulation
22 Film Formers & Plasticizers
21 Taste Masking
20 Lubricants & Glidants
18 Co-Processed Excipients
15 Solubilizers
13 Topical
11 Parenteral
9 Empty Capsules
8 Chewable & Orodispersible Aids
5 Coloring Agents
5 Emulsifying Agents
5 API Stability Enhancers
4 Rheology Modifiers
4 Vegetarian Capsules
2 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 21 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 62 Finished Drug Prices

2 US Medicaid Prescriptions
62 Finished Drug Prices

MARKET PLACE

19 APIs, 7 FDF Dossiers

19 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 1 Health Canada Patents

2 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 8 Others

2 EDQM
1 USP
8 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ API Ref.Price (USD/KG) : 40 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2PIERRE FABRE

filter Patent Number Reset all filters

2 All

01 18338489

02 18987262

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Blank

filter Expiration Date Reset all filters

2 All

01 22028-10-16

US Patents
Health Canada Patents

Product Main Page

01

PIERRE FABRE

PROPRANOLOL HYDROCHLORIDE

26th North American ISSX

Not Confirmed

PIERRE FABRE

26th North American ISSX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-16

PROPRANOLOL HYDROCHLORIDE

US Patent Number : 8338489

Drug Substance Claim :

Drug Product Claim :

Application Number : 205410

Patent Use Code : U-1496

Delist Requested :

Patent Use Description : METHOD TO TREAT HEMANG...

Patent Expiration Date : 2028-10-16

Portfolio PDF

Product Web Link

Digital Content

02

PIERRE FABRE

PROPRANOLOL HYDROCHLORIDE

26th North American ISSX

Not Confirmed

PIERRE FABRE

26th North American ISSX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-16

PROPRANOLOL HYDROCHLORIDE

US Patent Number : 8987262

Drug Substance Claim :

Drug Product Claim :

Application Number : 205410

Patent Use Code : U-1988

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-16

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?